突发利好！深夜大涨超70%

Group 1 - Verve Therapeutics' stock surged over 70% following an announcement by Eli Lilly to acquire the company for up to $1.3 billion, including a nearly $1 billion upfront payment and potential additional funds based on clinical milestones [3][4] - The acquisition price is set at $10.5 per share for all outstanding shares of Verve, indicating strong investor interest and confidence in the company's future prospects [4] - Verve is developing a groundbreaking in vivo gene editing drug, Verve-102, which utilizes CRISPR technology to modify liver cell DNA, potentially transforming the treatment of cardiovascular diseases from chronic care to a one-time therapy [4] Group 2 - The broader market saw declines in major indices, with the Dow Jones down 0.24%, S&P 500 down 0.29%, and Nasdaq down 0.40%, reflecting a mixed sentiment in the market despite the positive news for Verve [2] - In the biotech sector, BrainCo, a company focused on brain-computer interface technology, experienced a significant stock increase, reflecting investor enthusiasm for innovative health technologies [4][5] - The energy sector also saw gains, with major oil companies like Chevron and ExxonMobil rising over 1%, amid rising oil prices and geopolitical developments affecting energy supply [6][8]